In-depth: What the approval of flucytosine means for the treatment of cryptococcal meningitis in SA

After seemingly endless delays, a critically important drug for the treatment of cryptococcal meningitis (CM) was recently approved in South Africa.

Related Keywords

University Of Cape Town ,Western Cape ,South Africa ,South African ,Zackie Achmat ,Desmond Munemo ,Jacqui Miot ,Nelesh Govender ,Amir Shroufi ,Graeme Meintjes ,Yuven Gounden ,Khadija Jamaloodien ,Epidemiology Research Office ,Clinton Health Access Initiative ,World Health Organization ,Treatment Action Campaign ,Cape Department Of Health ,African Health Products Regulatory Authority ,Wits University Health Economics ,Medicines Committee ,National Institute For Communicable Diseases ,Pfizer ,National Department Of Health Ndo ,National Essential Medicine List Committee ,Clinicians Society ,Southern African ,Professor Graeme Meintjes ,National Department ,Sans Fronti ,Southern Africa ,National Institute ,Communicable Diseases ,Division Director ,Essential Medicines ,Western Cape Department ,Affordable Medicines ,Essential Medicines List ,Knowledge Hub ,Adult Hospital , ,